Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Dec;145(6):1271-9.

Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis

Affiliations

Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis

M C Dal Canto et al. Am J Pathol. 1994 Dec.

Abstract

Transgenic mice expressing mutant Cu,Zn superoxide dismutase (SOD), containing a substitution of glycine at position 93 by alanine, develop disease prevalently affecting motor neurons. Light microscopical and ultrastructural studies reveal that the earliest pathological features are microvesiculation of large neurons of the anterior horns of the spinal cord. These vacuoles originate from dilation of rough endoplasmic reticulum and from degenerating mitochondria. At the end stage of the disease, the microvesicular pattern gives way to atrophic anterior horns showing severe neuronal depletion and hyaline, filamentous inclusions in some of the surviving neurons. Posterior horn neurons and dorsal root ganglia are not affected. With disease progression, moderate degeneration of anterior and lateral columns, severe degeneration of anterior roots, and mild degeneration in posterior columns and roots become apparent. This study shows that a mutation in SOD, known to occur in a percentage of familial amyotrophic lateral sclerosis patients, may affect only selective neuronal populations, although SOD is a ubiquitous enzyme.

PubMed Disclaimer

References

    1. J Cell Biol. 1992 Nov;119(3):493-501 - PubMed
    1. Eur J Pharmacol. 1991 Nov 12;204(3):339-40 - PubMed
    1. Nature. 1993 Aug 12;364(6438):584 - PubMed
    1. Science. 1993 Aug 20;261(5124):1047-51 - PubMed
    1. Mol Chem Neuropathol. 1993 May-Jun;19(1-2):193-204 - PubMed

Publication types

Substances

LinkOut - more resources